Remove 2023 Remove Clinic Remove Community Remove Referral
article thumbnail

Risks and Needs: Lessons Learned from Assessing Patients Willingness to Receive Help for Social Risks in Primary Care [Social determinants and vulnerable populations]

Annals of Family Medicine

Context: In May 2023, Mayo Clinic implemented a revised screening tool to assess social determinants of health (SDOH) for its patients. Setting or Dataset: Secondary data on social needs screening and referral generated through Epic. Study Design and Analysis: Descriptive analysis of secondary data.

article thumbnail

Multisector Health Equity Coordination in a Midwestern Primary Care Practice, 2022-2023 [Social determinants and vulnerable populations]

Annals of Family Medicine

Multisector coordination is critical for effective screening and referral initiatives. Objective: To assess the function and impact of a new role, a Health Equity Coordinator, on the reach of the social needs screening and referral program.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A feasibility study of the Illuminate 360o approach for monitoring the implementation of a health system innovation [Mixed methods research]

Annals of Family Medicine

Setting: Alberta, Canada from May 2022 to October 2023. We employed diverse strategies to solicit respondent participation in clinics, provider networks, community and, social media. Participants provided short reflections about their surgical journey or referral experiences, along with elaborations in quantitative categories.

Referral 130
article thumbnail

Episode 384: Antiracism in Medicine – Episode 26 – Racial and Gender Health Disparities in Youth Suicide: Part 1

The Clinical Problem Solvers

Dr. Benton mentors clinical and research physicians, fellows, and postdoctoral trainees. She was awarded the Society of Biological Psychiatry Humanitarian Award and the Community Outreach Award by the American Foundation for Suicide Prevention. Dr. Kevin M.

article thumbnail

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

FDA Law Blog

That emergency declaration is set to expire on May 11, 2023. 180 days past May 11, 2023) for those telemedicine relationships established during the COVID-19 emergency. Comments, including data from research and clinical practice, that provides evidence that an alternate maximum day supply (other than the proposed 30-day supply).

article thumbnail

FDA Guidance Outlines a Framework for the Evaluation of Long-Term Neurodevelopmental Safety Studies in Neonatal Product Development

FDA Law Blog

To this end, FDA recently announced the publication of a guidance titled “Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development,” (the “Guidance”). This guidance finalizes a draft guidance issued in February 2023. What to measure, when, and for how long?

Clinic 64
article thumbnail

Leveraging U=U Interventions for Black Women With HIV

Physician's Weekly

The systematic review of peer-reviewed intervention was published from 2018 to 2023. The researchers recommended including community members in intervention design, healthcare systems, and policies. This message should be incorporated into counseling during routine clinic visits, especially for people recently diagnosed with HIV.